In the media 20 Nov 2024 Les enfants, grands oubliés de la recherche contre les maladies tropicales négligées Le Monde
Scientific articles 12 Nov 2024 Development and validation of ultra-performance liquid chromatography tandem mass spectrometry methods for the quantitative analysis of the antiparasitic drug DNDI-6148 in human plasma and various mouse biomatrices Journal of Chromatography B
Scientific articles 9 Nov 2024 Changes in lipid abundance are associated with disease progression and treatment response in chronic Trypanosoma cruzi infection Parasites Vectors
Viewpoints 7 Nov 2024 What the G20 Coalition for Local and Regional Production, Innovation, and Equitable Access should do next
Press releases 31 Oct 2024 DNDi welcomes new G20 coalition focused on innovation, local and regional production, and equitable access to health tools
Statements 30 Oct 2024 DNDi interventions at the 5th Meeting of the G20 Health Working Group and G20 Health Ministerial Meeting, 30-31 October 2024
Publications 29 Oct 2024 The Science Explained: Evaluating an alternative treatment regimen for fungal mycetoma
Scientific articles 22 Oct 2024 Climate change, migration, and health: perspectives from Latin America and the Caribbean The Lancet Regional Health – Americas
Scientific articles 17 Oct 2024 Immunotherapeutic strategies as potential treatment options for cutaneous leishmaniasis Vaccines
In the media 17 Oct 2024 ¿Dónde están los fondos para las enfermedades que atacan a mil millones de pobres? El País
News 10 Oct 2024 Nobel prize for chemistry awarded to Demis Hassabis and John Jumper for AlphaFold, an AI model used by DNDi for neglected diseases
News 4 Oct 2024 DNDi 2024 Projects of the Year recognize contributions of DNDi teams and partners working to deliver medical innovations for people affected by leishmaniasis and sleeping sickness
News 6 Sep 2024 Message on the passing of Dr Alwyn Mwinga from DNDi Executive Director Dr Luis Pizarro